Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in TLRY — Tilray Brands, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$85,879
-$71,904 QoQ
Shares Held
19,127
-21.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 235 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. TLRY ranks #44 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in TLRY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,879 19,127
2026-03-31 $157,783 24,387
2025-12-31 $633,788 70,187
2025-09-30 $193,100 111,619
2025-06-30 $23,091 56,323
2025-03-31 $67,471 102,231
2024-12-31 $135,054 101,545
2024-09-30 $209,052 118,780
2024-06-30 $252,762 152,267
2024-03-31 $351,609 142,352
2023-12-31 $267,866 116,464
2023-09-30 $328,650 137,511
2023-06-30 $123,826 79,376
2023-03-31 $217,147 85,829
2022-12-31 $248,308 92,308
2022-09-30 $308,473 112,172
2022-06-30 $376,081 120,539
2022-03-31 $997,722 128,407
2021-12-31 $214,168 30,465
2021-09-30 $170,783 15,127
2021-06-30 $188,176 10,408
2021-03-31 $145,221 6,389
2020-12-31 $34,005 4,117
2020-09-30 $63,480 13,089
2020-06-30 $12,072 1,698
2020-03-31 $20,963 3,047